Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3176 |
|
Actual shortage: | 259 (8%) | |
Anticipated shortage: | 5 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2903 (91%) | |
Discontinuation Reports |
355 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 333 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
33 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2023-05-06 | 2023-06-02 | 191874 |
APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2023-07-27 | 2023-09-28 | 200180 |
APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2023-11-10 | 2023-11-24 | 209933 |
APO-DARIFENACIN | 7.5MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-12-15 | 2024-08-15 | 213547 |
APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2023-12-22 | 2024-02-23 | 214229 |
APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2024-06-13 | 2024-09-06 | 230469 |
APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2024-06-13 | 2024-08-30 | 230474 |
APO-MELOXICAM | 7.5MG | TABLET | Actual shortage | 2024-09-12 | 2024-09-12 | 237357 |
APO-ALENDRONATE/VITAMIN D3 | 70MG 2800UNIT | TABLET | Resolved | 2017-07-17 | 2018-04-06 | 15962 |
APO-ALENDRONATE/VITAMIN D3 | 70MG 5600UNIT | TABLET | Resolved | 2017-11-27 | 2018-07-03 | 30793 |
APO-ALENDRONATE/VITAMIN D3 | 70MG 5600UNIT | TABLET | Resolved | 2018-11-27 | 2019-01-03 | 67708 |
APO-ALENDRONATE/VITAMIN D3 | 70MG 5600UNIT | TABLET | Resolved | 2020-11-26 | 2021-04-15 | 128922 |
APO-ALENDRONATE | 70MG | TABLET | Resolved | 2017-03-11 | 2017-06-05 | 633 |
APO-ALENDRONATE | 70MG | TABLET | Resolved | 2017-05-10 | 2017-07-19 | 9849 |
APO-ALENDRONATE | 70MG | TABLET | Resolved | 2017-06-19 | 2017-09-03 | 13300 |
APO-ALENDRONATE | 70MG | TABLET | Resolved | 2017-08-08 | 2017-12-31 | 18512 |
APO-ALENDRONATE | 70MG | TABLET | Resolved | 2018-04-04 | 2018-05-24 | 44966 |
APO-ALENDRONATE | 70MG | TABLET | Resolved | 2018-05-15 | 2018-07-03 | 49415 |
APO-ALENDRONATE | 70MG | TABLET | Resolved | 2018-07-04 | 2018-10-09 | 54162 |
APO-ALENDRONATE | 70MG | TABLET | Resolved | 2018-08-27 | 2018-11-26 | 59284 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-DIPYRIDAMOLE | 75MG | TABLET | Discontinued | 2019-12-20 | 2019-12-21 | 101880 |
APO-FUROSEMIDE | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |